Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 109
of 6Next
1:

Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed.

Sawada-Hirai R, Jiang I, Wang F, Sun SM, Nedellec R, Ruther P, Alvarez A, Millis D, Morrow PR, Kang AS.

J Immune Based Ther Vaccines. 2004 May 12;2(1):5.

PMID: 15140257 [PubMed - as supplied by publisher]

2:

Human monoclonal anti-protective antigen antibody completely protects rabbits and is synergistic with ciprofloxacin in protecting mice and guinea pigs against inhalation anthrax.

Peterson JW, Comer JE, Noffsinger DM, Wenglikowski A, Walberg KG, Chatuev BM, Chopra AK, Stanberry LR, Kang AS, Scholz WW, Sircar J.

Infect Immun. 2006 Feb;74(2):1016-24.

PMID: 16428748 [PubMed - indexed for MEDLINE]

3:

In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity.

Staats HF, Alam SM, Scearce RM, Kirwan SM, Zhang JX, Gwinn WM, Haynes BF.

Infect Immun. 2007 Nov;75(11):5443-52. Epub 2007 Aug 20.

PMID: 17709410 [PubMed - indexed for MEDLINE]

4:

Prophylaxis and therapy of inhalational anthrax by a novel monoclonal antibody to protective antigen that mimics vaccine-induced immunity.

Vitale L, Blanset D, Lowy I, O'Neill T, Goldstein J, Little SF, Andrews GP, Dorough G, Taylor RK, Keler T.

Infect Immun. 2006 Oct;74(10):5840-7.

PMID: 16988263 [PubMed - indexed for MEDLINE]

5:

Human monoclonal antibodies against anthrax lethal factor and protective antigen act independently to protect against Bacillus anthracis infection and enhance endogenous immunity to anthrax.

Albrecht MT, Li H, Williamson ED, LeButt CS, Flick-Smith HC, Quinn CP, Westra H, Galloway D, Mateczun A, Goldman S, Groen H, Baillie LW.

Infect Immun. 2007 Nov;75(11):5425-33. Epub 2007 Jul 23.

PMID: 17646360 [PubMed - indexed for MEDLINE]

6:

Induction of protective immunity to anthrax lethal toxin with a nonhuman primate adenovirus-based vaccine in the presence of preexisting anti-human adenovirus immunity.

Hashimoto M, Boyer JL, Hackett NR, Wilson JM, Crystal RG.

Infect Immun. 2005 Oct;73(10):6885-91.

PMID: 16177368 [PubMed - indexed for MEDLINE]

7:

Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model.

Peterson JW, Comer JE, Baze WB, Noffsinger DM, Wenglikowski A, Walberg KG, Hardcastle J, Pawlik J, Bush K, Taormina J, Moen S, Thomas J, Chatuev BM, Sower L, Chopra AK, Stanberry LR, Sawada R, Scholz WW, Sircar J.

Infect Immun. 2007 Jul;75(7):3414-24. Epub 2007 Apr 23.

PMID: 17452469 [PubMed - indexed for MEDLINE]

8:

Development of a competitive enzyme linked immunosorbent assay to identify epitope specific antibodies in recipients of the U.S. licensed anthrax vaccine.

Gubbins MJ, Schmidt L, Tsang RS, Berry JD, Kabani A, Stewart DI.

J Immunoassay Immunochem. 2007;28(3):213-25.

PMID: 17613668 [PubMed - indexed for MEDLINE]

9:

Human monoclonal antibodies that neutralize anthrax toxin by inhibiting heptamer assembly.

Wang F, Ruther P, Jiang I, Sawada-Hirai R, Sun SM, Nedellec R, Morrow PR, Kang AS.

Hum Antibodies. 2004;13(4):105-10.

PMID: 15671576 [PubMed - indexed for MEDLINE]

10:

A cationic lipid-formulated plasmid DNA vaccine confers sustained antibody-mediated protection against aerosolized anthrax spores.

Hermanson G, Whitlow V, Parker S, Tonsky K, Rusalov D, Ferrari M, Lalor P, Komai M, Mere R, Bell M, Brenneman K, Mateczun A, Evans T, Kaslow D, Galloway D, Hobart P.

Proc Natl Acad Sci U S A. 2004 Sep 14;101(37):13601-6. Epub 2004 Sep 1.

PMID: 15342913 [PubMed - indexed for MEDLINE]

11:

The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.

Welkos S, Little S, Friedlander A, Fritz D, Fellows P.

Microbiology. 2001 Jun;147(Pt 6):1677-85.

PMID: 11390699 [PubMed - indexed for MEDLINE]

12:

Rapid generation of an anthrax immunotherapeutic from goats using a novel non-toxic muramyl dipeptide adjuvant.

Kelly CD, O'Loughlin C, Gelder FB, Peterson JW, Sower LE, Cirino NM.

J Immune Based Ther Vaccines. 2007 Oct 22;5:11.

PMID: 17953756 [PubMed - in process]

13:

Selection and characterization of human antibodies neutralizing Bacillus anthracis toxin.

Zhou B, Carney C, Janda KD.

Bioorg Med Chem. 2008 Feb 15;16(4):1903-13. Epub 2007 Nov 5.

PMID: 18023190 [PubMed - indexed for MEDLINE]

14:

Immunogenicity of recombinant protective antigen and efficacy against aerosol challenge with anthrax.

Williamson ED, Hodgson I, Walker NJ, Topping AW, Duchars MG, Mott JM, Estep J, Lebutt C, Flick-Smith HC, Jones HE, Li H, Quinn CP.

Infect Immun. 2005 Sep;73(9):5978-87.

PMID: 16113318 [PubMed - indexed for MEDLINE]

15:

Effective mucosal immunity to anthrax: neutralizing antibodies and Th cell responses following nasal immunization with protective antigen.

Boyaka PN, Tafaro A, Fischer R, Leppla SH, Fujihashi K, McGhee JR.

J Immunol. 2003 Jun 1;170(11):5636-43.

PMID: 12759444 [PubMed - indexed for MEDLINE]

16:

An in vivo passive protection assay for the evaluation of immunity in AVA-vaccinated individuals.

Hewetson JF, Little SF, Ivins BE, Johnson WM, Pittman PR, Brown JE, Norris SL, Nielsen CJ.

Vaccine. 2008 Aug 5;26(33):4262-6. Epub 2008 Jun 12.

PMID: 18586363 [PubMed - indexed for MEDLINE]

17:

Effect of nasal immunization with protective antigen of Bacillus anthracis on protective immune response against anthrax toxin.

Gaur R, Gupta PK, Banerjea AC, Singh Y.

Vaccine. 2002 Jun 21;20(21-22):2836-9.

PMID: 12034111 [PubMed - indexed for MEDLINE]

18:

Protection against anthrax toxin by vaccination with a DNA plasmid encoding anthrax protective antigen.

Gu ML, Leppla SH, Klinman DM.

Vaccine. 1999 Jan 28;17(4):340-4.

PMID: 9987172 [PubMed - indexed for MEDLINE]

19:

Characterization of the human immune response to the UK anthrax vaccine.

Baillie L, Townend T, Walker N, Eriksson U, Williamson D.

FEMS Immunol Med Microbiol. 2004 Oct 1;42(2):267-70.

PMID: 15364114 [PubMed - indexed for MEDLINE]

20:

Mucosal immunization with a novel nanoemulsion-based recombinant anthrax protective antigen vaccine protects against Bacillus anthracis spore challenge.

Bielinska AU, Janczak KW, Landers JJ, Makidon P, Sower LE, Peterson JW, Baker JR Jr.

Infect Immun. 2007 Aug;75(8):4020-9. Epub 2007 May 14.

PMID: 17502384 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 109
of 6Next